Essential pro Stent
Coronary artery disease
Post-MarketActive
Key Facts
About iVascularU
iVascular is a privately-held, commercial-stage medical device company focused on the cardiovascular and neurovascular markets. Leveraging deep expertise in biopolymers, coatings, and drug delivery, the company has built a vertically integrated platform to develop and manufacture a portfolio of interventional devices, including the Angiolite drug-eluting stent and Luminor drug-coated balloon. With products approved in over 70 countries and a growing clinical evidence base, iVascular aims to be a European reference in vascular therapy through innovation and close collaboration with physicians.
View full company profileTherapeutic Areas
Other Coronary artery disease Drugs
| Drug | Company | Phase |
|---|---|---|
| MUTI™ Drug‑Eluting Stent | Meril | Commercial |
| Coronary Artery Bypass Grafts | Vascudyne | Pre-clinical |
| Premier DES | Relisys Medical Devices | Commercial |
| Release R DES | Relisys Medical Devices | Commercial |
| Pristine DES | Relisys Medical Devices | Commercial |
| BioMatrix family (Flex/Alpha) | Biosensors International | Commercial |
| Coronary Artery Disease Program | Elixir Medical | Pre-clinical |
| FGF-1 | Zhittya Genesis Medicine | Phase 2 |
| OMT-28 | OMEICOS Therapeutics | Phase 2 |
| Fantom Encore | REVA Medical | Commercial |
| Next-Gen Drug-Eluting Stents | Translumina | Development |
| Geographic Market Expansion | Translumina | Commercial |